NCT ID | NCT02756364 |
Title | MLN0128 in Combination With Fulvestrant in Women With Advanced or Metastatic Breast Cancer After Aromatase Inhibitor Therapy |
Recruitment | Active, not recruiting |
Gender | female |
Phase | Phase II |
Variant Requirements | yes |
Sponsors | Millennium Pharmaceuticals, Inc. |
Indications | |
Therapies | |
Age Groups: | senior adult |